Amanda Whittal

Amanda Whittal is a consultant at Dolon Ltd, a company specializing in strategic pricing and market access for rare and severe diseases.12 Some key points about Amanda Whittal:

Professional Background

• She is currently an Associate Director at Dolon Ltd3
• Amanda is a health psychologist by training3
• Her experience ranges from research and practice in individual health behavior to broader research and consulting in rare diseases3

Expertise and Work

• Amanda specializes in rare diseases and market access strategies2
• She has co-authored publications on topics like the economics of gene therapy innovation and pricing2
• Her work involves helping clients achieve better physical and mental health outcomes

Location and Company

• Amanda is based in Germany1
• Dolon Ltd, her employer, is headquartered in London, UK1
• The company has 51-200 employees and operates in the pharmaceutical manufacturing industry1

Publications and Research

Amanda has contributed to research and publications in the field of rare diseases, including:

• Co-authoring a paper on "Exploring the economics of gene therapy innovation and price" in January 20222
• Contributing to work on improving interpretation of evidence relating to quality of life in health technology assessments for rare disease treatments45

Amanda Whittal's LinkedIn username is amanda-whittal-9a465412, as mentioned in the query.